TrialSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2016

Phase II randomized, controlled trial of 1 day versus 3 days of dexamethasone combined with palonosetron and aprepitant to prevent nausea and vomiting in Japanese breast cancer patients receiving anthracycline-based chemotherapy.

Yoshimasa Kosaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.